EGFR and neoplasm: The clinical validity of ddPCR Lung cfDNA Assay was first evaluated in terms of the concordance of EGFR mutations detected between paired tumor tissue specimens and plasma samples obtained from 106 EGFR-TKIs treatment-naïve patients.